
Investornewsbreaks Annovis Bio Inc. (NYSE: ANVS) Receives NYSE Noncompliance Notice Over Market Cap And Equity Levels
(MENAFN- Investor Brand Network) Annovis Bio (NYSE: ANVS) , a late-stage clinical drug platform company focused on therapies for neurodegenerative diseases, disclosed it received a noncompliance notice from the New York Stock Exchange on March 26, 2025, …